Nutritional Management of the Patient With Type 2 Diabetes at Nutritional Risk or With Malnutrition in Clinical Practice
The objective of this observational study is to characterize the patient profile and nutritional treatment patterns of individuals with type 2 diabetes (T2D) or drug-induced diabetes who present with malnutrition, or are at risk of it, and who are prescribed a diabetes-specific oral nutritional supplement (ONS) that is high in calories and protein and contains soluble fiber. Participants will complete a series of questionnaires during visits 1 and 3.
Conditions studied
Type 2 Diabetes Mellitus (T2DM), Malnutrition, Malnourishment, Drug-Induced Diabetes
About this study
The objective of this observational study is to characterize the patient profile and nutritional treatment patterns of individuals with type 2 diabetes (T2D) or drug-induced diabetes who present with malnutrition, or are at risk of it, and who are prescribed a diabetes-specific oral nutritional supplement (ONS) that is high in calories and protein and contains soluble fiber. Participants will complete a series of questionnaires during visits 1 and 3.
Primary outcomes
- Descriptive of study population (Baseline visit (V1))
Eligibility information
Study locations
- Hospital Universitario Marqués de Valdecilla, Santander, Cantabria 39008 Spain
- Hospital Universitario Juan Ramón Jiménez, Huelva, Huelva 21005 Spain
- Hospital UniversitarioDoctor Negrín, Las Palmas de Gran Canaria, Las Palmas 35010 Spain
- Hospital La Princesa, Madrid, Madrid 28006 Spain
- Hospital Clínico San Carlos, Madrid, Madrid 28040 Spain
- Hospital Universitario La Paz, Madrid, Madrid 28046 Spain
- Hospital Virgen de la Victoria, Málaga, Malaga 29010 Spain
- Hospital Universitario Central de Asturias, Oviedo, Principality of Asturias 33011 Spain
- Hospital Universitario Virgen del Rocío, Seville, Sevilla 41005 Spain
- Hospital Universitario Virgen de la Macarena, Seville, Sevilla 41009 Spain
Showing 10 of 12 reported sites. See the official listing for all locations.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.